Pasireotide diaspartate
更新时间:2020-12-18 22:54:27
采购访问:1次
|
常用名 |
Pasireotide diaspartate |
CAS号 |
820232-50-6 |
价格 |
$需询单/100mg $需询单/250mg $需询单/500mg |
纯度 |
98.0% |
备货期 |
3天 |
库存 |
现货 |
产品网页 |
http://www.dcchemicals.com/product_show-Pasireotide_diaspartate.html |
产品详情(用途,包装等) Pasireotide, also known as SOM230, is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs. |
|